Burçin Yavuz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Burçin Yavuz has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- David Lee Kaplan
Department of Biomedical Engineering, Tufts University, Medford, MA 02155, USA
9 shared publications - Imran Vural
Department of Pharmaceutical Technology, Hacettepe University, Ankara, Turkey
7 shared publications Nurşen Ünlü
A Faculty of Pharmacy, Department of Pharmaceutical Technology , Hacettepe University , Ankara , Turkey
6 shared publications- Sibel Bozdağ Pehlivan
Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara 06230, Turkey
6 shared publications Abbas Kaffashi
Department of Nanotechnology and Nanomedicine, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey
3 shared publications- Bill Chiu
Division of Pediatric Surgery, Department of Surgery, Stanford University, Palo Alto, USA
3 shared publications
Latest Publications
- Open Access
- 24 November 2020
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 29 (2) , 248-256
NF-κB-mediated effects on behavior and cartilage pathology in a non-invasive loading model of post-traumatic osteoarthritis
- 24 November 2020
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 29 (2) , 248-256
Open AccessNF-κB-mediated effects on behavior and cartilage pathology in a non-invasive loading model of post-traumatic osteoarthritis
- Open Access
- 7 July 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (8) , 5375-5382
Silk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel
The sustained release of levonorgestrel, a contraceptive, from silk-based microneedle patches was demonstrated for transdermal delivery. Modifications in the formulation of the silk protein and drug loading enabled the tuning of drug loading and release rates from the microneedle patches over time. Sustained drug release reached up to 100 days when the drug was loaded directly inside the microneedles, while release continued for more than a year when the drug was loaded inside microparticles prior to casting inside the microneedle patches. When coupled with the shelf-stable, refrigeration-less features of the silk protein matrix utilized in the microneedle fabrication, these findings suggest that long acting contraception patches are feasible. This advance could provide practical options for women to have access to new options for protection against unwanted pregnancy.
- 7 July 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (8) , 5375-5382
Open AccessSilk Fibroin Microneedle Patches for the Sustained Release of Levonorgestrel
The sustained release of levonorgestrel, a contraceptive, from silk-based microneedle patches was demonstrated for transdermal delivery. Modifications in the formulation of the silk protein and drug loading enabled the tuning of drug loading and release rates from the microneedle patches over time. Sustained drug release reached up to 100 days when the drug was loaded directly inside the microneedles, while release continued for more than a year when the drug was loaded inside microparticles prior to casting inside the microneedle patches. When coupled with the shelf-stable, refrigeration-less features of the silk protein matrix utilized in the microneedle fabrication, these findings suggest that long acting contraception patches are feasible. This advance could provide practical options for women to have access to new options for protection against unwanted pregnancy.
- 1 October 2019
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 229 (4) , S210-S211
Optimizing Sustained Release Local Therapy: Single vs Dual Chemotherapy for the Treatment of Neuroblastoma
- 1 October 2019
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 229 (4) , S210-S211
Optimizing Sustained Release Local Therapy: Single vs Dual Chemotherapy for the Treatment of Neuroblastoma
- 23 September 2019
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 57 (3) , 249-254
The Effect of Quercus coccifera L. Extract on the Necrosis of Random-pattern Skin Flaps in Rats
- 23 September 2019
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 57 (3) , 249-254
The Effect of Quercus coccifera L. Extract on the Necrosis of Random-pattern Skin Flaps in Rats
- Open Access
- 1 May 2019
- Published by Elsevier in Journal of Controlled Release
- Vol. 301, 1-12
Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention
- 1 May 2019
- Published by Elsevier in Journal of Controlled Release
- Vol. 301, 1-12
Open AccessSustained release silk fibroin discs: Antibody and protein delivery for HIV prevention
- 1 September 2018
- Published by Elsevier in Journal of Controlled Release
- Vol. 285, 162-171
In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment
- 1 September 2018
- Published by Elsevier in Journal of Controlled Release
- Vol. 285, 162-171
In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment
- 29 July 2018
- Published by Wiley in Advanced Therapeutics
- Vol. 1 (6)
Pharmaceutical Approaches to HIV Treatment and Prevention
Human immunodeficiency virus (HIV) infection continues to pose a major infectious disease threat worldwide. It is characterized by the depletion of CD4+ T cells, persistent immune activation, and increased susceptibility to secondary infections. Advances in the development of antiretroviral drugs and combination antiretroviral therapy have resulted in a remarkable reduction in HIV‐associated morbidity and mortality. Antiretroviral therapy (ART) leads to effective suppression of HIV replication with partial recovery of host immune system and has successfully transformed HIV infection from a fatal disease to a chronic condition. Additionally, antiretroviral drugs have shown promise for prevention in HIV pre‐exposure prophylaxis and treatment as prevention. However, ART is unable to cure HIV. Other limitations include drug–drug interactions, drug resistance, cytotoxic side effects, cost, and adherence. Alternative treatment options are being investigated to overcome these challenges including discovery of new molecules with increased anti‐viral activity and development of easily administrable drug formulations. In light of the difficulties associated with current HIV treatment measures, and in the continuing absence of a cure, the prevention of new infections has also arisen as a prominent goal among efforts to curtail the worldwide HIV pandemic. In this review, the authors summarize currently available anti‐HIV drugs and their combinations for treatment, new molecules under clinical development and prevention methods, and discuss drug delivery formats as well as associated challenges and alternative approaches for the future.
- 29 July 2018
- Published by Wiley in Advanced Therapeutics
- Vol. 1 (6)
Pharmaceutical Approaches to HIV Treatment and Prevention
Human immunodeficiency virus (HIV) infection continues to pose a major infectious disease threat worldwide. It is characterized by the depletion of CD4+ T cells, persistent immune activation, and increased susceptibility to secondary infections. Advances in the development of antiretroviral drugs and combination antiretroviral therapy have resulted in a remarkable reduction in HIV‐associated morbidity and mortality. Antiretroviral therapy (ART) leads to effective suppression of HIV replication with partial recovery of host immune system and has successfully transformed HIV infection from a fatal disease to a chronic condition. Additionally, antiretroviral drugs have shown promise for prevention in HIV pre‐exposure prophylaxis and treatment as prevention. However, ART is unable to cure HIV. Other limitations include drug–drug interactions, drug resistance, cytotoxic side effects, cost, and adherence. Alternative treatment options are being investigated to overcome these challenges including discovery of new molecules with increased anti‐viral activity and development of easily administrable drug formulations. In light of the difficulties associated with current HIV treatment measures, and in the continuing absence of a cure, the prevention of new infections has also arisen as a prominent goal among efforts to curtail the worldwide HIV pandemic. In this review, the authors summarize currently available anti‐HIV drugs and their combinations for treatment, new molecules under clinical development and prevention methods, and discuss drug delivery formats as well as associated challenges and alternative approaches for the future.
- 2 May 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (25) , e1800598
Programmable Hydrogel Ionic Circuits for Biologically Matched Electronic Interfaces
The increased need for wearable and implantable medical devices has driven the demand for electronics that interface with living systems. Current bioelectronic systems have not fully resolved mismatches between engineered circuits and biological systems, including the resulting pain and damage to biological tissues. Here, salt/poly(ethylene glycol) (PEG) aqueous two‐phase systems are utilized to generate programmable hydrogel ionic circuits. High‐conductivity salt‐solution patterns are stably encapsulated within PEG hydrogel matrices using salt/PEG phase separation, which route ionic current with high resolution and enable localized delivery of electrical stimulation. This strategy allows designer electronics that match biological systems, including transparency, stretchability, complete aqueous‐based connective interface, distribution of ionic electrical signals between engineered and biological systems, and avoidance of tissue damage from electrical stimulation. The potential of such systems is demonstrated by generating light‐emitting diode (LED)‐based displays, skin‐mounted electronics, and stimulators that deliver localized current to in vitro neuron cultures and muscles in vivo with reduced adverse effects. Such electronic platforms may form the basis of future biointegrated electronic systems.
- 2 May 2018
- Published by Wiley in Advanced Materials
- Vol. 30 (25) , e1800598
Programmable Hydrogel Ionic Circuits for Biologically Matched Electronic Interfaces
The increased need for wearable and implantable medical devices has driven the demand for electronics that interface with living systems. Current bioelectronic systems have not fully resolved mismatches between engineered circuits and biological systems, including the resulting pain and damage to biological tissues. Here, salt/poly(ethylene glycol) (PEG) aqueous two‐phase systems are utilized to generate programmable hydrogel ionic circuits. High‐conductivity salt‐solution patterns are stably encapsulated within PEG hydrogel matrices using salt/PEG phase separation, which route ionic current with high resolution and enable localized delivery of electrical stimulation. This strategy allows designer electronics that match biological systems, including transparency, stretchability, complete aqueous‐based connective interface, distribution of ionic electrical signals between engineered and biological systems, and avoidance of tissue damage from electrical stimulation. The potential of such systems is demonstrated by generating light‐emitting diode (LED)‐based displays, skin‐mounted electronics, and stimulators that deliver localized current to in vitro neuron cultures and muscles in vivo with reduced adverse effects. Such electronic platforms may form the basis of future biointegrated electronic systems.
- 26 March 2018
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 4 (5) , 1708-1715
Stabilization of RNA Encapsulated in Silk
The use of mRNA and miRNA as diagnostic parameters and therapeutic agents has drawn wide interest both clinically and in research. However, RNA is a labile molecule, which requires strict storage conditions, often including cold temperatures or dry environments, in order to preserve RNA integrity. Achieving this requires huge costs for storage and added difficulty in transport. To address these issues, we introduce a system to encapsulate and store it long-term in dried silk fibroin matrices. At temperatures up to 45 °C, mRNA samples stored in lyophilized silk matrices showed good stability over 1 week, as measured by real-time PCR to assess transcript recovery. While the presence of the silk interfered with the generation of cDNA required for quantitation at roughly 1% w/v (400:1 silk:RNA mass), this phenomenon was resolved by the use of commercial RNA purification kits for silk concentrations up to 4% w/v. A higher concentration of silk correlated with increased thermal protection. As an alternative to lyophilization, RNA was simply air-dried in the presence of aqueous fibroin to create storage matrices. While air-dried matrices composed of low silk content were not protective, higher concentrations were protective and progressively lost additional water over time of storage because of the overall hydrophobic nature of the system. Taken together, these findings provide a new and potentially simpler method for preserving RNA samples for long-term storage and transportation, acting primarily on a water exclusion mechanism.
- 26 March 2018
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 4 (5) , 1708-1715
Stabilization of RNA Encapsulated in Silk
The use of mRNA and miRNA as diagnostic parameters and therapeutic agents has drawn wide interest both clinically and in research. However, RNA is a labile molecule, which requires strict storage conditions, often including cold temperatures or dry environments, in order to preserve RNA integrity. Achieving this requires huge costs for storage and added difficulty in transport. To address these issues, we introduce a system to encapsulate and store it long-term in dried silk fibroin matrices. At temperatures up to 45 °C, mRNA samples stored in lyophilized silk matrices showed good stability over 1 week, as measured by real-time PCR to assess transcript recovery. While the presence of the silk interfered with the generation of cDNA required for quantitation at roughly 1% w/v (400:1 silk:RNA mass), this phenomenon was resolved by the use of commercial RNA purification kits for silk concentrations up to 4% w/v. A higher concentration of silk correlated with increased thermal protection. As an alternative to lyophilization, RNA was simply air-dried in the presence of aqueous fibroin to create storage matrices. While air-dried matrices composed of low silk content were not protective, higher concentrations were protective and progressively lost additional water over time of storage because of the overall hydrophobic nature of the system. Taken together, these findings provide a new and potentially simpler method for preserving RNA samples for long-term storage and transportation, acting primarily on a water exclusion mechanism.